China Gingko Crackdown Reveals Broad Quality Problems
This article was originally published in PharmAsia News
Executive Summary
Amid another drug quality scare, this time involving Gingko extract products, the China FDA has worked through a holiday weekend to name and shame the good, the bad and the ugly. And in a revealing move, the agency has disclosed an unusually high number of bad apples.